Abdominal Neoplasms - 350 Studies Found Terminated : Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma : Fallopian Tube Cancer Ovarian Cancer Peritoneal Cavity Can : 2008-04-03 : Drug: atrasentan hydrochloride Terminated : Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer : Fallopian Tube Cancer Ovarian Cancer Peritoneal Cavity Can : 2008-04-03 : Biological: Allopurinol All pa Active, not recruiting : Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer : Ovarian Cancer Peritoneal Cavity Cancer : 2008-04-03 : Biological: filgrastim Drug: carboplatin Terminated : A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer. : Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer : 2008-03-10 : Drug: Alemtuzumab will be given Alemtuzumab therapy three times in your first week on the study and then Completed : Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin) : Ovarian Cancer, Primary Peritoneal Cancer : 2008-03-05 : Drug: M200 (Volociximab) 7.5 m Withdrawn : Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer : Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer : 2008-03-06 : Drug: Femara 2.5 mg by mouth d Completed : A Phase I Study of NY-ESO-1 Overlapping Peptides (OLP4) Immunoadjuvants Montanide and Poly-ICLC Vaccination of Epithelial Ovarian Cancer (EOC), Fallopian Tube, or Primary Peritoneal Cancer Patients in Second or Third Remission : Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Pe : 2008-02-04 : Biological: NY-ESO-1 OLP4 1 mg Withdrawn : DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer : Ovarian Cancer Primary Peritoneal Cancer : 2008-01-16 : Biological: DCVax-L and T Cells Arm A Withdrawn : Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer : Breast Cancer Cervical Cancer Endometrial Cancer : 2008-01-25 : Genetic: gene expression analysis Genetic: Completed : AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer : Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal Ca : 2007-12-14 : Drug: motesanib diphosphate <<< Previous | Next >>>
